Avedro Revenue and Competitors
Estimated Revenue & Valuation
- Avedro's estimated annual revenue is currently $36.2M per year.
- Avedro received $25.0M in venture funding in May 2018. 0
- Avedro's total funding is $218.5M.
Employee Data
- 00
Avedro's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Clinical Affairs | Reveal Email/Phone |
2 | VP Regulatory Affairs | Reveal Email/Phone |
3 | Chief Business Officer | Reveal Email/Phone |
Avedro Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is Avedro?
Avedro is a privately held pharmaceutical and medical device company advancing the science and technology of corneal cross-linking and refractive correction.
keywords:Biotechnology,Cleantech,Healthcare,Medical Devices,Pharmaceuticals,Wind Power
$218.5M
Total Funding
N/A
Number of Employees
$36.2M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avedro News
2022-04-17 - Glaukos Technologies Featured in Numerous Scientific ...
Avedro is a wholly owned subsidiary of Glaukos Corporation. Forward-Looking Statements. All statements other than statements of historical facts...
2022-04-17 - Saluda Medical Appoints Robert Palmisano to Board of ...
Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced...
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 0 | N/A | $5.9M |
#2 | $32M | 0 | N/A | N/A |
#3 | $3.5M | 0 | N/A | $170.2M |
#4 | $18.9M | 0 | N/A | $244.9M |
#5 | $0.1M | 1 | -50% | N/A |
Avedro Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2009-05-12 | $10.0M | Undisclosed | Flagship Ventures of Cambridge | Article |
| 2011-07-08 | $25.0M | C | SCP Vitalife | Article |
| 2012-02-22 | $26.0M | Undisclosed | Article | |
| 2013-03-07 | $43.0M | D | Abingworth | Article |
| 2015-04-08 | $7.2M | Undisclosed | Article | |
| 2015-11-16 | $32.0M | Undisclosed | InterWest | Article |
| 2017-04-28 | $42.0M | Undisclosed | HealthQuest Capital | Article |
| 2018-05-03 | $25.0M | Undisclosed | Lilly Asia Ventures | Article |